The SGLT2 inhibitor empagliflozin inhibits skeletal muscle fibrosis in naturally aging male mice through the AMPKα/MMP9/TGF-β1/Smad pathway
Year: 2024
Type: article
Source: Biogerontology
Authors: Qixuan Huang, Jie Chen, Siqi Liao, Jiangchuan Long, Ronghua Fang, Yusen He, Peiyun Chen, Dongfang Liu
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Award: G8428353814
OpenAlex ID: W4392165339